Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet Diabetes and Endocrinology

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-8587(16)30402-8PMID 27964837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive Value of Admission Hemoglobin A1c on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes

  2015cited by this paper
• Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes

  2015cited by this paper
• Use of incretin-based therapy in hospitalized patients with hyperglycemia.

  2014cited by this paper
• Hospital Discharge Algorithm Based on Admission HbA1c for the Management of Patients With Type 2 Diabetes

  2014cited by this paper
• Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes

  2013cited by this paper
• Reshaping diabetes care: the fundamental role of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists in clinical practice.

  2013cited by this paper
• Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes

  2013cited by this paper
• Hypoglycemia and risk of death in critically ill patients.

  2012cited by this paper
• A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency

  2012cited by this paper
• Adjunctive Sitagliptin Therapy in Postoperative Cardiac Surgery Patients: A Pilot Study

  2012cited by this paper
• Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.

  2012cited by this paper
• Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes

  2012cited by this paper
• Update on inpatient glycemic control in hospitals in the United States.

  2011cited by this paper
• Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

  2011cited by this paper
• Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

  2010cited by this paper
• Evaluation of hospital glycemic control at US academic medical centers.

  2009cited by this paper
• Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.

  2009cited by this paper
• Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward

  2009cited by this paper
• Insulin Therapy and Glycemic Control in Hospitalized Patients With Diabetes During Enteral Nutrition Therapy

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

  2009cited by this paper
• Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial

  2009cited by this paper
• Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts.

  2008cited by this paper
• Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)

  2008cited by this paper
• Severe hypoglycemia in critically ill patients: Risk factors and outcomes*

  2007cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2002cited by this paper
• Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

  2001cited by this paper
• Drug-induced hypoglycemic coma in 102 diabetic patients.

  1999cited by this paper
• Early postoperative glucose control predicts nosocomial infection rate in diabetic patients.

  1998cited by this paper

• Comprehensive Inpatient Glycemic Management

  2026cites this paper
• Perioperative Medication Management for Patients with Diabetes

  2026cites this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.

  2025cites this paper
• Exploring the heterogeneity in recurrent episode lengths based on quantile regression.

  2025cites this paper
• Re-starting or initiating guideline-recommended hypoglycemic agents for patients admitted with hyperglycemic crisis

  2025cites this paper
• Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization

  2025influential citation
• Non-insulin diabetes medicines: a narrative review for anaesthetists and intensivists

  2025cites this paper
• A Real-World Study of Oral Anti-Hyperglycemic Agents as Compared to Basal Insulin in Hospitalized Patients with Type 2 Diabetes.

  2025cites this paper
• Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD)

  2025cites this paper
• 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

  2025cites this paper
• Inpatient Diabetes Management in Special Populations (Elderly, Cystic Fibrosis, Pregnancy, Chronic Kidney Disease, and Liver Dysfunction)

  2025cites this paper
• Caring for patients with diabetes in the outpatient surgical setting: current recommendations and controversies

  2024cites this paper
• Evaluation of pharmacist‐initiated glycemic control in adult medicine patients with diabetes

  2024cites this paper
• In-hospital linagliptin for management simplification and hypoglycemia reduction in very old patients with type 2 diabetes.

  2024cites this paper
• Management of Hyperglycemia in Hospitalized Patients

  2024cites this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025.

  2024cites this paper
• How Would You Treat This Inpatient With Type 2 Diabetes Mellitus? Grand Rounds Discussion From Beth Israel Deaconess Medical Center

  2024influential citation
• Treatment of Diabetes in Hospitals With Noninsulin Medications Is a Research Priority.

  2024cites this paper
• Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.

  2024cites this paper
• Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery

  2024cites this paper
• The Impact of Diabetes on Abdominoplasty Outcomes: A Systematic Review and Meta-Analysis

  2024cites this paper
• [Non-Insulin Antidiabetic Agents in the Management of Hyperglycaemia of Non-Critical Hospitalized Patients].

  2024cites this paper
• Control hospitalario de la diabetes y de la hiperglucemia: una auditoría en hospitales españoles

  2023cites this paper
• Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial)

  2023cites this paper
• Safety and efficacy of non-insulin therapy in non-critically ill hospitalized patients with type 2 diabetes mellitus.

  2023cites this paper
• Inpatient management of diabetes and hyperglycaemia: an audit of Spanish hospitals.

  2023cites this paper
• The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors.

  2023cites this paper
• Positionspapier: Operation und Diabetes mellitus (Update 2023)

  2023cites this paper
• Diabetesmanagement im Krankenhaus (Update 2023)

  2023cites this paper
• Terapéutica no insulínica para los pacientes hospitalizados con diabetes tipo 2

  2023cites this paper
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2024.

  2023cites this paper
• Effectiveness and safety of new oral and injectable agents for in-hospital management of type 2 diabetes in general wards: systematic review and meta-analysis.

  2022cites this paper
• Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials

  2022cites this paper
• Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study

  2022cites this paper
• Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control

  2022cites this paper
• Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal–Bolus Insulin Regimen: A Prospective Randomized Study

  2022cites this paper
• Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices

  2022cites this paper
• Glycemic Management of Hospitalized Patients Receiving Nutrition Support.

  2022cites this paper
• Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non‐inferiority randomized trial

  2022cites this paper
• Abordaje integral de las personas con diabetes tipo 2. Área de Conocimiento de Diabetes de la Sociedad Española de Endocrinología y Nutrición

  2022cites this paper
• Gaps in our knowledge of managing inpatient dysglycaemia and diabetes in non‐critically ill adults: A call for further research

  2022cites this paper
• Preoperative carbohydrate loading with individualized supplemental insulin in diabetic patients undergoing gastrointestinal surgery: A randomized trial.

  2022cites this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cites this paper
• Hyperglycemia in hospitalized patients of a tertiary care hospital: prevalence and treatment in two cross-sectional evaluations (2011-2020)

  2022cites this paper
• Diabetes mellitus y COVID-19: fisiopatología y propuesta de tratamiento para el control glucémico en el tiempo de la pandemia

  2021influential citation
• Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives

  2021cites this paper
• Type 2 diabetes management in people aged over seventy-five years: targets and treatment strategies.

  2021cites this paper
• Management of diabetes and hyperglycaemia in the hospital.

  2021cites this paper
• Inpatient hyperglycemia and transitions of care: a systematic review.

  2021cites this paper
• Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge

  2021cites this paper
• Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in Hospitalized Patients With Diabetes

  2021cites this paper
• Preoperative Management of Endocrine, Hormonal, and Urologic Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.

  2021cites this paper
• Simplified glycaemic management for patients with type 2 diabetes admitted for acute decompensated heart failure using linagliptin.

  2021cites this paper
• Management of older hospitalized patients with type 2 diabetes using linagliptin: Lina-Older Study.

  2021cites this paper
• Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure

  2021cites this paper
• Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes

  2021cites this paper
• Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Sitagliptin phosphate monohydrate.

  2021cites this paper
• The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors.

  2021cites this paper
• Evidence-based therapeutics for hyperglycemia in hospitalized noncritically ill patients

  2021cites this paper
• Terapia basada en incretinas para control glucémico de los pacientes hospitalizados con diabetes tipo 2: una revisión sistemática

  2021cites this paper
• Glycemic Control in Hospitalized Stroke Patients: A Review

  2021cites this paper
• Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure

  2021cites this paper
• Incretin-based therapy for glycemic control of hospitalized patients with type 2 diabetes: a systematic review.

  2021cites this paper
• Preoperative optimization of diabetes

  2021cites this paper
• E cacy And Safety of Empagli ozin Continuation in Patients With Type 2 Diabetes Hospitalised For Acute Decompensated Heart Failure

  2021cites this paper
• Annals for Hospitalists Inpatient Notes - How We Treat Hyperglycemia in the Hospital

  2021cites this paper
• Perioperative Evaluation and Management of Endocrine Disorders.

  2020cites this paper
• A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

  2020cites this paper
• Management of Inpatient Hyperglycemia and Diabetes in Older Adults.

  2020cites this paper
• Preoperative carbohydrate loading in diabetic patients undergoing gastrointestinal surgery: A pilot randomized trial

  2020cites this paper
• Inpatient Hyperglycemia Management and COVID-19

  2020cites this paper
• Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in the Inpatient Setting

  2020cites this paper
• Perioperative glucose management: Current status and future directions.

  2020cites this paper
• Effect of Sitagliptin and Glimepiride on Pancreatic Beta-Cells during the Treatment of Type-2 Diabetic Mellitus by Statistical Analysis

  2020cites this paper
• Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis

  2020cites this paper
• CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTINUED ON ORAL ANTIDIABETES MEDICATIONS IN THE HOSPITAL.

  2020cites this paper
• Efficacy of Sitagliptin Versus Glimepiride 1-3 mg for Treatment of Type-2 Diabetes Patients

  2020cites this paper
• Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era

  2020cites this paper
• DPP4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2020cites this paper
• Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial

  2020cites this paper
• Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close

  2020cites this paper
• In-Patient Management of Hyperglycemia during COVID-19 Pandemic

  2020cites this paper
• Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial

  2020cites this paper
• PERI-OPERATIVE MANAGEMENT IN DIABETES MELLITUS

  2020cites this paper
• SAFETY AND EFFICACY OF DDP4-INHIBITORS FOR MANAGEMENT OF HOSPITALIZED GENERAL MEDICINE AND SURGERY PATIENTS WITH TYPE 2 DIABETES.

  2020cites this paper
• Efficacy and Safety of Dapagliflozin in Acute Heart Failure: Rationale and Design of the DICTATE-AHF trial.

  2020cites this paper
• Challenges and Strategies for Inpatient Diabetes Management in Older Adults

  2020cites this paper
• Hospital Diabetes Meeting 2020

  2020cites this paper
• Inpatient Hypoglycemia: The Challenge Remains

  2020cites this paper
• Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic

  2020cites this paper
• Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes.

  2020cites this paper
• Evaluation of the Safety and Efficacy of Metformin Use in Hospitalized, Non–Critically Ill Patients

  2020cites this paper
• A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes

  2019cites this paper
• All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

  2019cites this paper
• Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial

  2019cites this paper
• Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery

  2019cites this paper
• Debate on Insulin vs Non-insulin Use in the Hospital Setting—Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?

  2019cites this paper
• A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial

  2019cites this paper
• Management of Glucose Control in Noncritically Ill, Hospitalized Patients Receiving Parenteral and/or Enteral Nutrition: A Systematic Review

  2019cites this paper
• Use of Insulin in the Inpatient Setting: Need for Continued Use

  2019cites this paper